Clinical Trial Update: ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids [Phase 2]

View source ↗

Summary

ARISTOCRAT is a Phase 2 blinded trial evaluating temozolomide with or without cannabinoids in glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Glioblastoma

Drugs mentioned

• Cannabinoids (cannabinoids)
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Birmingham | Conditions: Glioblastoma, Brain Tumor | Phase 2 | Status: RECRUITING